Out of specification and out of trend investigations are becoming increasingly important in the pharmaceutical industry due to an increase in the number of citations given for inadequate investigations. In 2022 approximately 37 % of 483 warning letters from the FDA were issued due to failure to thoroughly review any unexplained discrepancy or the failure of the batch or any of its components to meet any of its specifications. In many cases this is down to companies being unaware of the regulatory guidance requirements while performing investigations.

 

This course is aimed at helping pharmaceutical companies to understand the guidance available to thoroughly investigate out of specifications and out of trends.

Price: €250

About the course:

Outlines how to thoroughly investigate out of specification (OOS) and out of trend (OOT) results using scientifically justified evidence to determine the root cause:

  • Identifying and assessing OOS results

  • Phase I and Phase II laboratory investigations

  • Manufacturing investigations

  • Microbiological investigations

  • Out of trend (OOT) investigations

  • Tools to help identify root causes

  • Reviewing OOS/OOT results

  • How to conclude the investigation

Who is This Course For?

This course is designed for professionals in  Good Manufacturing Practice (GMP) activities . It is particularly valuable for:

The objective of this course is to equip those who complete the training with the knowledge and tools to adequately investigate and or review out of specifications and out of trends.

Requirements

There are no prior qualifications or experience required to enrol in this course. It is open to all individuals interested in learning about GMP principles and practices.